Brain network connectivity underlying remission in early psychosis: a whole brain model approach

Mana, L.; Lopez-Gonzalez, A.; Aleman Gomez, Y.; Baumann, P.; Jenni, R.; Alameda, L.; Abrahamyan Empson, L.; Klauser, P.; Conus, P.; Hagmann, P.; Vila Vidal, M.; Deco, G.

doi:10.1101/2023.11.28.568844

bioRxiv · 10.1101/2023.11.28.568844

Brain network connectivity underlying remission in early psychosis: a whole brain model approach

Mana, L.·Lopez-Gonzalez, A.·Aleman Gomez, Y.·Baumann, P.·Jenni, R.·Alameda, L.·Abrahamyan Empson, L.·Klauser, P.·Conus, P.·Hagmann, P.·Vila Vidal, M.·Deco, G.

View original source ↗Export metadata ↓

Abstract

BackgroundAlterations in brain connectivity occur early during psychosis and underlie the clinical manifestations of the illness as well as patient functioning and outcome. After a first episode of psychosis (FEP), different trajectories are possible and best described by the clinical-staging model that places the patient along a continuum of conditions: from non-remitting chronic symptoms to full-remission, often followed by relapses. However, little is known about the differences in brain connectivity that could underlie these differences in clinical outcome. MethodsIn this study, we included resting-state fMRI and DSI data from a cohort of 128 healthy controls (HC) and 88 patients with early psychosis (EP) stratified based on their ability to remit after the FEP. In particular we focused on differences between stage IIIb,c remitting-relapsing (EP3R) and stage IIIa non-remitting (EP3NR) patients. We investigated alterations in resting-state functional connectivity (FC), and combined information derived from fMRI and DSI into generative whole-brain models of each condition to explore the underlying mechanisms. ResultsOpposite alterations in FC could be found in patients as compared to HC, depending on their stage. In non-remitting patients (EP3NR), we observed a reduction of FC, aligned with the reduced structural connectivity found in previous studies, while remitting-relapsing patients (EP3R) showed increased FC, potentially indicating a relevant compensatory mechanism. By means of a whole-brain network model, we showed that in HC a subset of areas is characterized by increased stability to prevent an oversynchronisation of the network, while in EP3 patients such property is lost. This alteration was more relevant in the EP3R than in EP3NR patients, probably indicating a compensatory response to the reduced effective conductivity (global coupling) highlighted by the model in both EP3 conditions as compared to controls. ConclusionsThese findings highlight the significance of categorizing patients into subgroups based on the progression of their psychotic disorders, providing insights into the factors contributing to heterogeneity in functional alterations. They enhance our understanding of the interplay between structural and functional properties, shedding light on the mechanisms of psychosis emergence, remission and progression, with potential implications for future therapeutic advancements.

Source connections

Published article ↗

Explore related subjects

neuroscience Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Mana, L., Lopez-Gonzalez, A., Aleman Gomez, Y., Baumann, P., Jenni, R., Alameda, L., Abrahamyan Empson, L., Klauser, P., Conus, P., Hagmann, P., Vila Vidal, M., Deco, G.. 2023-11-28. Brain network connectivity underlying remission in early psychosis: a whole brain model approach. https://doi.org/10.1101/2023.11.28.568844

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Neurodegeneration-inducing macromolecules exit the brain via nanovascular conduits formed by reticular fibroblasts

Accumulation of proteins such as amyloid beta (Abeta), hyperphosphorylated tau and alpha-synuclein within the brain alters neural information processing and causes neurodegeneration(1-3), but how toxic solutes are cleared from the brain remains highly controversial(4,5). Proposed exit routes include efflux across endothelial cells into the blood(6,7), and movement to the pial surface via vasomotion-induced pumping along spaces within arteriolar smooth muscle(8) or via outflow along the perivascular space of ascending venules promoted by water flux through astrocytes (the glymphatic system(9)). From the pial surface of the brain, drainage may continue to dural lymphatics, along the outer sheaths of exiting cranial nerves and across the cribriform plate(10-14). We now report the presence, in mice and humans, of 2 micron diameter conduits that remove fluorescently labelled tau and Abeta from the brain. These conduits form a spatially-organised mesh within the walls of penetrating arterioles and pial arteries, and around the surface of ascending venules and deep cerebral and pial veins. They course through the pial and arachnoid layers to span the CSF space, wrapping the brain and cranial nerves. They are formed of reticular fibroblasts, which label for VE-cadherin(15) and PDGFRalpha(16), the lymphatic markers(17) podoplanin, VEGFR3 and Prox1, and reticular fibroblast extracellular matrix components collagen I and VI(16,18-20). Parenchymal tau drains from the brain at a similar rate via arteriolar conduits and via conduits around venules, arguing against preferential removal by a glymphatic mechanism. In Alzheimer's disease model mice, Abeta is seen traversing these lymph node-like conduits. Modulation of molecular transfer via this route may accelerate or delay cognitive decline, and slowed transfer from arteriolar to pial-arachnoid conduits may initiate cerebral amyloid angiopathy.

neuroscience↗

bioRxiv2026

Analysis of the influence of gradual changes in matrix sentence similarity on neural envelope tracking

Neural tracking of speech is a well-established phenomenon in neuroscience. However, for speech signals with a fixed structure, significant correlations between speech envelopes and neurophysiological representations occur even for unheard sentences. We exploit a structured speech-in-noise matrix hearing test (Oldenburger Sentence Test, OLSA) to systematically quantify the relationship between acoustic sentence similarity and neural tracking. Simultaneous magnetoencephalography (MEG) and 76-channel electroencephalography (EEG) data, including 16 channels positioned directly around the ears (ear-EEG), were recorded from 21 young adults with normal hearing during the presentation of clean-speech audiobooks and OLSA sentences at six signal-to-noise ratios. A linear decoder trained on audiobooks reconstructed OLSA sentence envelopes. Reconstruction accuracies were compared using a linear mixed model across heard (matched) and unheard (mismatched) sentences of varying acoustic similarity. Significant reconstruction accuracies were achieved across MEG, EEG, and ear-EEG for both matched and mismatched sentences. For mismatched sentences, these accuracies gradually increased with their acoustic similarity to the heard speech data. The high similarity between sentences, which is especially prominent in matrix tests, can cause significant spurious tracking for mismatched stimuli. This effect can reach levels comparable to those of matched sentences and can be mistaken for true neural tracking. Robust neural tracking across modalities further supported the established viability of ear-EEG compared to whole-head systems.

neuroscience↗

bioRxiv2026

Seizures and tauopathy following neurotrauma are mediated by prion protein and metabotropic glutamate receptor 5

Traumatic brain injury (TBI) is one of the world's leading causes of death and disability and a major risk factor for dementias. The primary dementia associated with TBI is chronic traumatic encephalopathy (CTE), a neurodegenerative disease classified as a tauopathy, in which toxic tau molecules lead to disease pathologies and degeneration. The processes that lead to tauopathy and subsequent dementia after TBI remain unclear. Here, we built upon the finding that seizures after TBI may be a mechanism leading to tauopathy, by dissecting the functions of the metabotropic glutamate receptor 5 - cellular prion protein (mGluR5-PrPC) pathway. We delivered TBI to larval in a blast paradigm, and quantified aggregation of Tau via a genetically-encoded Tau-GFP fusion reporter. Zebrafish larvae lacking prp2 (homolog of mammalian cellular Prion Protein, PrPC) displayed a 168% increase in post-traumatic seizures activity after TBI. An mGluR5 agonist (CHPG) reduced post-traumatic seizures, whereas an mGluR5 antagonist (MPEP) increased post-traumatic seizures. Moreover, agonizing mGluR5 reduced tau aggregation and antagonizing mGluR5 increased tau burden. Larvae seizing from convulsants, rather than TBI, were treated with CHPG/MPEP and provided a similar pattern of outcomes, suggesting seizures may be a factor needed for mGluR5 activity to influence tau aggregation. The PrPC-mGluR5 pathway is proposed as one candidate pathomechanism linking TBI to subsequent seizures and tauopathy, and thus it warrants investigation as a target for prophylactic interventions.

neuroscience↗